This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignee: Innovation Ulster Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Victor Alan Gault: Innovator in Cognitive Function Therapies
Introduction
Victor Alan Gault is a prominent inventor based in Ballymoney, GB, known for his significant contributions to the field of cognitive function therapies. With two patents to his name, Gault’s work focuses on innovative peptide analogues that address disorders linked with dysfunctional synaptic transmission. His research is paving the way for new treatments aimed at improving cognitive function and delaying the onset of neurological diseases.
Latest Patents
Gault's innovative spirit is exemplified through his latest patents. One of his notable inventions is titled "Use of GLP-1 analogues for the treatment of disorders associated with dysfunctional synaptic transmission." This invention revolves around a peptide analogue of glucagon-like peptide-1 (7-36), which aims to prophylactically prevent, improve, or even reverse diminished cognitive function. By increasing the long-term potentiation (LTP) of synaptic transmission, this patent holds promise for treating cognitive decline due to neurodegeneration as well as addressing cognitive issues associated with trauma or aging.
Another key patent is "Use of GIP for the treatment of disorders associated with dysfunctional synaptic transmission." This invention describes a peptide consisting of at least 12 amino acid residues from the N-terminal end of gastric inhibitory polypeptide, or an analogue thereof. Similar to the previous patent, the aim is to improve or reverse decreased cognitive performance by modulating LTP of synaptic transmission, thus offering valuable insights and therapies for cognitive dysfunction from various causes, including hyperexcitability-type disorders.
Career Highlights
Victor Alan Gault operates under Innovation Ulster Limited, where he further develops his groundbreaking ideas and works towards translating them into viable therapeutic options. His career trajectory is marked by a commitment to advancing our understanding of cognitive function and identifying innovative solutions that can positively impact patient care.
Collaborations
Throughout his career, Gault has collaborated with esteemed colleagues, including Peter Raymond Flatt and Christian Holscher. These partnerships enhance the collaborative nature of research and innovation, providing a multidisciplinary approach to tackling complex challenges in cognitive health.
Conclusion
Victor Alan Gault’s contributions to the realm of cognitive therapies highlight his status as a leading inventor in the field. Through his patents, he is not only innovating treatments that aim to improve cognitive function but also providing hope for those affected by neurological diseases. His work at Innovation Ulster Limited, along with collaborations with fellow researchers, underscores the importance of innovation in creating a brighter future for cognitive health solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile